Abstract:Background: Recent studies have found that Phosphodiesterase-4 (PDE4) is closely related to the pathogenesis of depression, cognitive impairment and neurological impairment. Objective: Our objective is to develop potent inhibitors of the high-affinity phosphodiesterase 4D isoform (PDE4D) that can serve as radioligands for Positron Emission Tomography (PET) imaging, thereby advancing research in the field of neurological diseases. Methods: We employed a multi-step approach combining three-dimensional quantitative structure-activity relationship (3D-QSAR) modeling, molecular docking, classification techniques, and CoMSIA analysis to investigate the conformational relationship of highaffinity PDE4D inhibitors as PET ligands. ADMET and Drug-likeness predictions were also conducted. By utilizing these methods, our aim was to identify more potent PDE4D inhibitors. Results: The results showed that the CoMSIA model with the best principal component scores (n=7) had a cross-validated Q2 value of 0.602 and a non-cross-validated R2 value of 0.976. These results affirmed the excellent predictive capability of the established CoMSIA model. Analysis of the generated 3D-QSAR contour plots highlighted specific regions in the molecular structure of the compounds that can be further optimized and modified. Guided by the contour plots, we designed 100 novel PDE4D inhibitors, and molecular docking was performed for the top 4 compounds with high activity. The molecular docking scores were promising, and ADMET and drug similarity predictions yielded satisfactory results. Taking into consideration these factors, compound 51c was determined to be the optimal compound, laying a solid foundation for further research. Conclusion: For the continued development of PDE4D PET radioligand, these models and new compounds' developing methodology offer a theoretical foundation and crucial references.

3d-Qsar Study Of Potent Inhibitors Of Phosphodiesterase-4 Using A Comfa Approach

A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors

Discover Natural Compounds As Potential Phosphodiesterase-4B Inhibitors Via Computational Approaches

Phosphodiesterase-4(PDE4) As a Target for Anti-Inflammatory Drug Discovery: Present and Prospect

3D-QSAR Studies on High-affinity Phosphodiestera

3D-QSAR Study for Inhibitors of Cyclin-Dependent Kinase 4

3D-QSAR Modeling of Phosphodiesterase-5 Inhibitors: Evaluation and Comparison of the Receptor- and Ligand-Based Alignments

3D-QSAR Studies on 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors by Comparative Molecular Field Analysis (Comfa)

Receptor and ligand-based 3D-QSAR study on a series of pyrazines/pyrrolidylquinazolines as inhibitors of PDE10A enzyme

3D-QSAR Study on Phenoxyalkylamine Compounds of Α1-Adrenoceptor Antagonist

Design, synthesis and biological evaluation of 2,4-disubstituted oxazole derivatives as potential PDE4 inhibitors

3D-QSAR Studies on Fluoropyrrolidine Amides As Dipeptidyl Peptidase IV Inhibitors by CoMFA and CoMSIA

3D-QSAR Studies on AChE Inhibitory Activities of 2-Phenoxy-indan-1-one Derivatives

Pharmacophore Modeling and Virtual Screening for the Discovery of New Type 4 Camp Phosphodiesterase (pde4) Inhibitors

Studies of H4R Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics

Qsar of Pyrazole Oxadiazole Derivatives As S1p1 Agonists Studied by Comfa, Comsia and Docking

3D-QSAR, Docking, and Molecular Dynamics Simulations Studies on Quinazoline Derivatives As PAK4 Inhibitors

A 3D-QSAR Study of Catechol-O-methyltransferase Inhibitors Using CoMFA and CoMSIA

3D-Qsar Studies on Glycogen Phosphorylase Inhibitors by Flexible Comparative Molecular Field Analysis

3d-Qsar Analysis On Pyrrolopyridine Analogs As Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (Mk-2) Inhibitors

3-DQSAR Study on the Analogues of 3-phenyl-1-indan-amines as SSRIs by the Comparative Molecular Field Analysis(CoMFA)